Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
120 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mylan Investigational Site
Amman, Jordan
- Mylan Investigational Site
Irbid, Jordan
- Mylan Investigational Site
Banská Bystrica, Slovakia
- Mylan Investigational Site
Bardejov, Slovakia
- Mylan Investigational Site
Bratislava, Slovakia
- Mylan Investigational Site
Dolný Kubín, Slovakia
- Mylan Investigational Site
Košice, Slovakia
- Mylan Investigational Site
Levice, Slovakia
- Mylan Investigational Site
Sabinov, Slovakia
- Mylan Investigational Site
Stropkov, Slovakia
- Mylan Investigational Site
Trebišov, Slovakia
- Mylan Investigational Site
Trenčín, Slovakia
- Mylan Investigational Site
Šahy, Slovakia
- Mylan Investigational Site
Štúrovo, Slovakia
- Mylan Investigational Site
Žilina, Slovakia
- Mylan Investigational Site
Johannesburg, Gauteng, South Africa
- Mylan Investigational Site
Durban, KwaZulu-Natal, South Africa
- Mylan Investigational Site
Cape Town, Western Cape, South Africa
- Mylan Investigational Site
Cape Town, Western Cape, South Africa
- Mylan Investigational Site
Worcester, Western Cape, South Africa
- Mylan Investigational Site
Bloemfontein, South Africa
- Mylan Investigational Site
Seoul, Gyeonggi-do, South Korea
- Mylan Investigational Site
Suwon, Gyeonggi-do, South Korea
- Mylan Investigational Site
Seoul, South Korea
- Mylan Investigational Site
Kaohsiung City, Taiwan
- Mylan Investigational Site
Taipei, Taiwan
- Mylan Investigational Site
Chandler, Arizona, United States
- Mylan Investigational Site
Bell Gardens, California, United States
- Mylan Investigational Site
Fresno, California, United States
- Mylan Investigational Site
Greenbrae, California, United States
- Mylan Investigational Site
Long Beach, California, United States
- Mylan Investigational Site
Los Angeles, California, United States
- Mylan Investigational Site
Los Gatos, California, United States
- Mylan Investigational Site
Mission Hills, California, United States
- Mylan Investigational Site
National City, California, United States
- Mylan Investigational Site
Northridge, California, United States
- Mylan Investigational Site
Orange, California, United States
- Mylan Investigational Site
Palm Springs, California, United States
- Mylan Investigational Site
Spring Valley, California, United States
- Mylan Investigational Site
Tustin, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2014
- Primary completion
- 31 Dec 2015
- Completion
- 31 Dec 2015
- Last update posted
- 3 Mar 2022
- Registered enrollment
- 560
- Registry id
- NCT02227875
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.